JPS5250793B1 - - Google Patents

Info

Publication number
JPS5250793B1
JPS5250793B1 JP43038393A JP3839368A JPS5250793B1 JP S5250793 B1 JPS5250793 B1 JP S5250793B1 JP 43038393 A JP43038393 A JP 43038393A JP 3839368 A JP3839368 A JP 3839368A JP S5250793 B1 JPS5250793 B1 JP S5250793B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP43038393A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5250793B1 publication Critical patent/JPS5250793B1/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP43038393A 1967-06-08 1968-06-06 Pending JPS5250793B1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1695428A DE1695428C3 (de) 1967-06-08 1967-06-08 Derivate des 5-Mercaptopyridoxins und Verfahren zu deren Herstellung
DE19681770222 DE1770222A1 (de) 1967-06-08 1968-04-18 Neue schwefelhaltige Pyridinderivate

Publications (1)

Publication Number Publication Date
JPS5250793B1 true JPS5250793B1 (ja) 1977-12-27

Family

ID=25755557

Family Applications (1)

Application Number Title Priority Date Filing Date
JP43038393A Pending JPS5250793B1 (ja) 1967-06-08 1968-06-06

Country Status (10)

Country Link
US (2) US3625949A (ja)
JP (1) JPS5250793B1 (ja)
AT (2) AT278792B (ja)
CH (9) CH551973A (ja)
DE (2) DE1695428C3 (ja)
ES (1) ES354787A1 (ja)
FR (1) FR7678M (ja)
GB (1) GB1156769A (ja)
NL (1) NL155730B (ja)
SE (1) SE346995B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK143335C (da) * 1975-05-09 1981-12-14 Merck & Co Inc Analogifremgangsmaade til fremstilling af bis(5-mercaptopyridoxin)-ethan-1,2-disulfonat
US4046897A (en) * 1975-05-09 1977-09-06 Merck & Co., Inc. 5-Mercaptopyridoxine alkanesulfonates and methods of use and pharmaceutical compositions
EP1659881B1 (en) 2003-08-06 2019-04-03 Senomyx Inc. Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
US20060045953A1 (en) * 2004-08-06 2006-03-02 Catherine Tachdjian Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers
AR052477A1 (es) * 2005-02-04 2007-03-21 Senomyx Inc Moleculas que comprenden restos organicos conectados como modificadores del sabor para composiciones comestibles
ES2776973T3 (es) * 2005-02-04 2020-08-03 Firmenich Incorporated Compuestos que comprenden restos de heteroarilo unidos y su uso como nuevos modificadores del sabor umami, saborizantes y potenciadores del sabor para composiciones comestibles
TW200715993A (en) * 2005-06-15 2007-05-01 Senomyx Inc Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers
EP3398452A3 (en) 2006-04-21 2018-11-28 Senomyx, Inc. Comestible compositions comprising high potency savory flavorants, and processes for producing them

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633927A (ja) * 1958-03-21

Also Published As

Publication number Publication date
CH565765A5 (ja) 1975-08-29
CH552590A (de) 1974-08-15
CH560191A5 (ja) 1975-03-27
CH560192A5 (ja) 1975-03-27
DE1770222A1 (de) 1971-11-11
DE1695428B2 (de) 1978-02-02
GB1156769A (en) 1969-07-02
ES354787A1 (es) 1969-11-01
NL6808029A (ja) 1968-12-09
US3625949A (en) 1971-12-07
CH551972A (de) 1974-07-31
DE1695428C3 (de) 1978-10-05
US3755336A (en) 1973-08-28
CH554863A (de) 1974-10-15
DE1695428A1 (de) 1971-04-15
AT278792B (de) 1970-02-10
SE346995B (ja) 1972-07-24
NL155730B (nl) 1978-02-15
CH555827A (de) 1974-11-15
CH565764A5 (ja) 1975-08-29
AT278793B (de) 1970-02-10
FR7678M (ja) 1970-02-16
CH551973A (de) 1974-07-31

Similar Documents

Publication Publication Date Title
AU425114B2 (ja)
AU416737B2 (ja)
AU2277767A (ja)
AU342066A (ja)
AU2528767A (ja)
AU610966A (ja)
AU2116667A (ja)
AU2256867A (ja)
AU1273466A (ja)
AU2454867A (ja)
AU2977667A (ja)
AU3189468A (ja)
BE692198A (ja)
BE692492A (ja)
BE698932A (ja)
BE692780A (ja)
BE692779A (ja)
AU34866A (ja)
BE705584A (ja)
BE692778A (ja)
CH560192A5 (ja)
BE692552A (ja)
BE692199A (ja)
BE692654A (ja)
AU25066A (ja)